Soutenir la recherche

Actualités

RespiDART: Frontiers in Drug Development against Respiratory Viruses

29 novembre 2018

Vendredi 30 novembre

11h50-12h00 Risk factors for RSV severity in immunocompetent and immonucompromised adults presenting in an emergency department - Dr FOURATI

12h00-12h10 Non-targeted diagnosis of multiple viral infections by means of shotgun metagenomic using deep sequencing - Dr FOURATI

 

RespiDART: Frontiers in Drug Development against Respiratory Viruses - 29 au 30 novembre 2018 - Miami, USA

Précédent Toutes les actualités Suivant